InProTher
early-stage biotechnology company
InProTher has raised €6.0M across 1 funding round from 2 investors, most recently a Seed round in May 2023. Based in Copenhagen, Denmark; active in Healthtech. Data as of 4 Nov 2026.
Copenhagen, Denmarkwww.inprother.com ↗
Total raised
€6.0M
€6,000,000
Funding rounds
1
Investors
2
distinct backers
Active since
2023-05
latest 2023-05
Funding by year
EUR raised per yearInProTher — funding by year — interactive chart.
Data table
| InProTher — funding by year | |
|---|---|
| 2023 | €6.0M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Seed
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round- 2023-05-24Seed€6.0MEuropean Innovation Council (EIC),Private Investors
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-05-24 | Seed | €6.0M | European Innovation Council (EIC),Private Investors | View deal → |
Investors
2European Innovation Council (EIC)Private Investors
Related news
Similar companies
same sector, similar size- Hedia€8.7MDenmark · Healthtech
- Notify Therapeutics€5.0MDenmark · Healthtech
- Teton€4.8MDenmark · Healthtech
- Draupnir Bio€12MDenmark · Healthtech
- Hemi Health€4.0MDenmark · Healthtech
- Brainreader€6.6MDenmark · Healthtech
Global coverage: FundingData